Clinical and laboratory implications of acute HIV-1 infection

Clinical Microbiology Newsletter

Volumn 22, Issue 5, 2000, Pages 33-37

  Poon, Samuel H ^a   Rosenberg, Eric S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24;

ACUTE DISEASE; ANTIGEN DETECTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LYMPHOCYTE COUNT; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; SYMPTOMATOLOGY; T LYMPHOCYTE SUBPOPULATION; VIRUS DETECTION;

EID: 0034161801     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(00)88132-5     Document Type: Article

References (20)

1. Anonymous. 1997. Update: Trends in AIDS incidence - United States, 1996. MMWR - Morbidity & Mortality Weekly Report 46:861-867.
2. Satcher, D. 1999. The global HIV/AIDS epidemic. JAMA 281:1479-1480.
3. Jacquez, J.A. et al. 1994. Role of the primary infection in epidemics of HIV infection in gay cohorts. J. Acquired Immune Defic. Syndr. 7:1169-1184.
4. Rosenberg, E.S. et al. 1999. Acute HIV fection among patients tested for mononucleosis. New Eng. J. Med. 340:969-970.
5. Schacker, T. et al. 1996. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125:257-264. [Erratum, Ann. Intern. Med. 1997, 126:174.]
6. Rosenberg, E.S. and D. Cotton. 1997. Primary HIV infection and the acute retroviral syndrome. AIDS Clinical Care 9:22-25.
7. Vanhems, P. et al. 1999. Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. J. Acquired Immune Defic. Syndr. 21:99-106.
8. Kahn, J.O. and B. Walker. 1998. Current concepts: Acute human immunodeficiency virus type 1 infection. New Eng. J. Med. 339:33-39.
9. Tindall, B. et al. 1989. Severe clinical manifestations of primary HIV infection. AIDS 3:747-749.
10. + T-cell responses associated with control of viremia. Science 278:1447-1450.
11. Rick, J.D. et al. 1999. Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series. 130:37-39.
12. Quinn, T.C. 1997. Acute primary HIV infection. JAMA 278:58-62.
13. Busch, M.P. et al. 1995. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 35:91-97.
14. Cooper, D.A. et al. 1988. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J. Infect. Dis. 157: 889-896.
15. Musey, L. et al. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. New Engl. J. Med. 337:1267-1274.
16. Borrow, P. et al. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:205-211.
17. Mellors, J.W. et al. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170. [Erratum, Science 1997, 275:14.]
18. Haigwood, N.L. et al. 1996. Passive immune globulin therapy in the SIV/ macaque model: Early intervention can alter disease profile. Immunol. Lett. 51:107-114.
19. Janssen, R.S. et al. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48.
20. Carpenter, C.C.J. et al. 1998. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the international AIDS society - USA panel. JAMA 280:78-86.